Skip to content

Phase IV Clinical Trial of Suhuang Zhike Capsule in the Treatment of Cough Variant Asthma

Phase IV Clinical Trial of Suhuang Zhike Capsule in the Treatment of Cough Variant Asthma

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025306
Enrollment
Unknown
Registered
2019-08-22
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cough variant asthma

Interventions

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The following criteria must be fully complied with before they can be included in the test (1) Clinical diagnosis of cough variant asthma; (2) It conforms to the syndrome differentiation criteria of wind evil invading the lung and lung qi losing circulation; (3) Aged >= 18 years; (4) Voluntary participation in the clinical trial, informed consent and signature of informed consent.

Exclusion criteria

Exclusion criteria: The following criteria must not be met before they can be included in the test (1) ALT, AST > upper limit of normal reference value 1.5 times or Scr > upper limit of normal reference value; (2) having a long history of alcoholism or drug abuse; (3) Complicated with serious cardiovascular, cerebrovascular or hematopoietic diseases; (4) Mental or mental disorders; (5) Pregnant and lactating women; (6) allergic history to the ingredients of the tested drugs; (7) Has participated in other clinical trials in the past one month; (8) Researchers do not consider it appropriate to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
12-lead electrocardiogram;Chest X-ray examination;Routine blood test;Urinary routine;liver function;renal function;Pregnancy test;

Countries

China

Contacts

Public ContactZhan Hongchun

China-Japan Friendship Hospital

13466560915@139.com+86 13466560915

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026